Nipro announces US launch of Elisio-HX medium-cutoff dialyser
Nipro Corporation has announced the US commercial launch of Elisio-HX, a medium-cutoff dialyser featuring super high-flux membrane technology.
Enabled by the recent US Food and...
First patient randomised in trial of phosphate transporter inhibitor in treatment of hyperphosphatemia in...
R1 Therapeutics has announced that the first patient has been randomised in its global phase 2b trial of AP306, a first-in-class pan phosphate transporter...
Paragonix announces “landmark” long-distance donor kidney journeys
Paragonix Technologies has announced the completion of two landmark kidney transplants utilising the KidneyVault portable renal perfusion system.
Originating from the same donor at The...
Xeltis secures additional funding to finalise US pivotal trial of aXess vascular access conduit
Xeltis has announced an additional €20.5m of new funding from new and existing shareholders, with the proceeds to be used to finalise the ongoing...
